Article
Functional analysis of alleged NOGGIN mutation G92E disproves its pathogenic relevance.
PloS one - 1 Jan 2012
Zimmer Julia, Doelken Sandra C, Horn Denise, Groppe Jay C, Shore Eileen M, Kaplan Frederick S, Seemann Petra
Abstract excerpt
We identified an amino acid change (p.G92E) in the Bone Morphogenetic Protein antagonist NOGGIN in a 22-month-old boy who presented with a unilateral brachydactyly type B phenotype. Brachydactyly type B is a skeletal malformation that has been associated with increased Bone Morphogenetic Protein pathway activation in other patients. Previously, the amino acid change p.G92E in NOGGIN was described as causing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
